Table 1.
Digitally quantified CD3, CD4, CD8, CD20 and CD45RO density (cells/mm2) and their distribution and correlation with clinicopathological variables (chi-square and Fisher’s exact tests)
| CD3 | CD4 | CD8 | CD20 | CD45RO | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤1000 | >1000 | P | ≤550 | >550 | P | ≤500 | >500 | P | ≤400 | >400 | P | ≤250 | >250 | P | |
| Age | 0.624 | 0.029 | 0.856 | 0.573 | 0.263 | ||||||||||
| ≤65 | 159 | 62 | 146 | 74 | 101 | 121 | 178 | 45 | 149 | 72 | |||||
| >65 | 225 | 78 | 173 | 133 | 141 | 161 | 253 | 55 | 190 | 115 | |||||
| Gender | 0.004 | 0.788 | 0.783 | 0.122 | 0.946 | ||||||||||
| Female | 112 | 60 | 103 | 70 | 77 | 94 | 135 | 40 | 110 | 62 | |||||
| Male | 272 | 80 | 216 | 137 | 165 | 188 | 296 | 60 | 229 | 125 | |||||
| Weight loss | 0.791 | 0.328 | 0.082 | 0.936 | 0.699 | ||||||||||
| <10% | 346 | 127 | 283 | 189 | 211 | 259 | 388 | 90 | 303 | 169 | |||||
| >10% | 38 | 12 | 36 | 17 | 31 | 22 | 43 | 9 | 36 | 17 | |||||
| Smoking | 0.589 | 0.635 | 0.096 | 0.002 | 0.882 | ||||||||||
| Never | 11 | 6 | 9 | 9 | 10 | 8 | 15 | 3 | 12 | 6 | |||||
| Present | 242 | 91 | 204 | 129 | 142 | 191 | 260 | 78 | 212 | 121 | |||||
| Previous | 131 | 43 | 106 | 69 | 90 | 83 | 156 | 19 | 115 | 60 | |||||
| ECOG | 0.029 | 0.259 | 0.166 | 0.106 | 0.012 | ||||||||||
| 0 | 215 | 96 | 181 | 131 | 133 | 178 | 244 | 68 | 186 | 125 | |||||
| 1 | 139 | 38 | 116 | 61 | 91 | 87 | 154 | 28 | 124 | 55 | |||||
| 2 | 30 | 6 | 22 | 15 | 18 | 17 | 33 | 4 | 29 | 7 | |||||
| Histology | 0.040 | 0.118 | 0.574 | 0.573 | 0.109 | ||||||||||
| LUSC | 221 | 72 | 191 | 104 | 136 | 155 | 245 | 52 | 188 | 106 | |||||
| LUAD | 160 | 64 | 124 | 101 | 105 | 121 | 180 | 47 | 147 | 78 | |||||
| LULCC | 0 | 3 | 1 | 1 | 0 | 3 | 2 | 1 | 0 | 3 | |||||
| LUADSC | 2 | 1 | 2 | 1 | 1 | 2 | 3 | 0 | 3 | 0 | |||||
| NOS | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | |||||
| tStage | 0.653 | 0.031 | 0.270 | 0.270 | 0.342 | ||||||||||
| T1a | 8 | 3 | 6 | 7 | 7 | 4 | 9 | 4 | 9 | 3 | |||||
| T1b | 44 | 23 | 39 | 29 | 30 | 38 | 53 | 16 | 46 | 22 | |||||
| T1c | 67 | 25 | 49 | 43 | 41 | 50 | 69 | 23 | 58 | 34 | |||||
| T2a | 89 | 34 | 74 | 48 | 53 | 71 | 103 | 22 | 73 | 48 | |||||
| T2b | 53 | 19 | 39 | 33 | 28 | 43 | 59 | 13 | 40 | 32 | |||||
| T3 | 75 | 25 | 67 | 35 | 48 | 52 | 86 | 15 | 73 | 29 | |||||
| T4 | 48 | 11 | 45 | 12 | 35 | 24 | 52 | 7 | 40 | 19 | |||||
| nStage | 0.397 | 0.354 | 0.270 | 0.115 | 0.115 | ||||||||||
| N0 | 258 | 102 | 216 | 146 | 163 | 197 | 288 | 77 | 229 | 133 | |||||
| N1 | 86 | 24 | 66 | 45 | 49 | 62 | 98 | 14 | 69 | 42 | |||||
| N2 | 40 | 14 | 37 | 16 | 30 | 23 | 45 | 9 | 41 | 12 | |||||
| pStage | 0.118 | 0.001 | 0.015 | 0.067 | 0.029 | ||||||||||
| I | 150 | 66 | 124 | 94 | 95 | 121 | 168 | 51 | 138 | 78 | |||||
| II | 129 | 47 | 99 | 80 | 73 | 105 | 150 | 31 | 105 | 74 | |||||
| III | 105 | 27 | 96 | 33 | 74 | 56 | 113 | 18 | 96 | 35 | |||||
| Differentation | 0.071 | 0.907 | 0.715 | 0.676 | 0.235 | ||||||||||
| Well | 149 | 70 | 128 | 87 | 97 | 122 | 182 | 39 | 132 | 87 | |||||
| Intermediate | 179 | 53 | 144 | 91 | 108 | 122 | 186 | 48 | 155 | 76 | |||||
| Poor | 56 | 17 | 47 | 29 | 37 | 38 | 63 | 13 | 52 | 24 | |||||
| Vasc+ | 1.000 | 0.464 | 0.238 | 0.249 | 1.000 | ||||||||||
| No | 315 | 113 | 257 | 173 | 192 | 237 | 349 | 86 | 278 | 153 | |||||
| Yes | 68 | 25 | 60 | 33 | 48 | 44 | 80 | 13 | 59 | 33 | |||||
P-values below 0.05 are highlighted in bold. CD, cluster of differentiation; ECOG, eastern cooperative oncology group; NOS, no otherwise specified.